What is the role of Fine Needle Aspiration Cytology (FNAC) in the diagnosis and management of ocular or adnexal lesions in adult patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fine Needle Aspiration Cytology in Ophthalmology

Definition and Role of FNAC in Ophthalmic Practice

Fine needle aspiration cytology (FNAC) is a minimally invasive, safe, and cost-effective diagnostic tool that has become increasingly valuable in the evaluation of orbital and ocular adnexal lesions, providing accurate preoperative diagnosis without the morbidity associated with open biopsy. 1, 2

  • FNAC involves obtaining cellular material through a small-caliber needle, either with or without suction, to establish cytological diagnosis of space-occupying lesions in the orbit and periocular region 1, 2
  • The technique is particularly advantageous in the confined orbital space where lesions can cause proptosis, altered vision, and significant pressure on the globe 1
  • Primary lacrimal and adnexal gland neoplasms represent approximately 9% of orbital fine-needle aspirations in specialized centers 1

Indications for FNAC in Ophthalmology

Primary Diagnostic Applications

  • Lacrimal gland tumors: FNAC is indicated when noninvasive imaging techniques fail to confirm or rule out neoplastic lesions of the lacrimal gland 1
  • Eyelid lesions: Sebaceous carcinoma of the meibomian glands and other eyelid tumors can be accurately diagnosed through FNAC 1
  • Orbital masses: Deep-seated orbital lesions that present as space-occupying masses with proptosis or visual disturbance warrant FNAC evaluation 2, 3
  • Suspected metastatic disease: FNAC is most useful in diagnosing metastasis to the orbit or confirming recurrence of previously treated tumors 2, 3

Specific Clinical Scenarios

  • Lymphoid lesions: FNAC can identify orbital lymphomas that require specific medical therapy rather than surgical intervention 2
  • Inflammatory lesions: Non-resectable inflammatory orbital masses can be diagnosed through FNAC, avoiding unnecessary surgery 2
  • Benign resectable neoplasms: FNAC allows planning of limited, conservative surgery for confirmed benign lesions in cosmetically sensitive areas 1

Technical Approach and Optimization

Ultrasound Guidance

Ultrasound-guided FNAC significantly improves diagnostic accuracy and specimen adequacy compared to palpation-guided techniques. 4, 5, 3

  • USG-guided FNAC achieved 91.7% adequate material in one large series of 266 cases 3
  • Ultrasound guidance allows real-time needle visualization, confirms accurate sampling, and is superior to palpation-guided biopsy in terms of accuracy and patient comfort 5, 3
  • Image guidance is particularly valuable for deep-seated lesions and smaller masses where blind aspiration has higher inadequacy rates 3

Specimen Adequacy and Processing

  • Onsite cytopathology evaluation: The presence of an onsite cytopathologist significantly reduces inadequate samples (1% vs 12.6%) and improves diagnostic sensitivity (96.2% vs 78.2%) 4
  • When onsite cytopathology is unavailable, at least 3 passes should be performed on lymph nodes and 6-7 passes on solid masses to maximize diagnostic yield 4
  • Smear preparation techniques: Both air-dried smears (for rapid Diff-Quik staining) and alcohol-fixed smears (for Papanicolaou staining) should be prepared 4
  • Cell block preparation: Essential for ancillary studies including immunohistochemistry, flow cytometry, and molecular testing 4

Ancillary Testing Requirements

  • Flow cytometry: Collection of material in tissue culture media (Roswell Park Memorial Institute medium) is critical for suspected lymphoid lesions to allow immunophenotypic analysis 4
  • Immunohistochemistry: Cell block material enables characterization of tumor immunophenotype, particularly valuable for metastatic lesions to guide search for primary tumor 4
  • Molecular studies: FISH for major translocations and PCR for gene rearrangements may be necessary for definitive diagnosis in certain cases 4

Diagnostic Accuracy and Limitations

Performance Characteristics

  • High diagnostic accuracy: FNAC of lacrimal and adnexal tumors demonstrates 100% correlation with surgical follow-up in reported series 1
  • Sensitivity and specificity: The technique shows good sensitivity and specificity when performed by experienced practitioners with appropriate ancillary techniques 6, 2
  • Speed and cost-effectiveness: FNAC provides rapid diagnosis with low cost/benefit ratio compared to open biopsy 6, 1

Common Diagnostic Categories

Benign lesions:

  • Benign mixed tumors (pleomorphic adenomas) of the lacrimal gland can be diagnosed using standard criteria for salivary gland-type tumors 1
  • Inflammatory lesions including orbital pseudotumor and specific infections 2

Malignant lesions:

  • Adenoid cystic carcinoma of the lacrimal gland 1
  • Sebaceous carcinoma of the meibomian glands 1
  • Metastatic carcinomas to the orbit 2, 3
  • Lymphomas (requiring flow cytometry for definitive subtyping) 4, 2

Inadequate Samples and Repeat Aspiration

  • Inadequate specimen definition: Insufficient amount of well-preserved lesional material for confident diagnosis by the pathologist 4
  • Factors increasing inadequacy: Smaller lesion size, increased depth, and cystic or necrotic components 4, 3
  • Management of inadequate samples: Repeat FNA under ultrasound guidance with additional steps to optimize specimen adequacy 4
  • For cystic lesions, directed sampling of solid components improves diagnostic yield 4, 7

Indeterminate Results

  • Adequate but indeterminate samples: Sufficient lesional material present, but definite conclusions cannot be made due to the inherent nature of the process 4
  • Follow-up approach: Discussion with cytopathologist guides decision to repeat FNA or proceed to core biopsy 4
  • Core needle biopsy option: After initial inadequate or indeterminate FNA, core biopsy shows high adequacy (95%) and accuracy (94-96%) with low complications (1%) 4

Critical Pitfalls and Limitations

Technical Challenges

  • Limited experience: The most important disadvantage stems from limited experience in cytological diagnosis of orbital and soft tissue tumors 6, 2
  • Lack of standardization: Absence of standardized and uniform reporting system for soft tissue and orbital FNAC 6
  • Sampling errors: Spindle cell lesions and cystic degeneration can lead to nondiagnostic aspirates requiring repeat sampling 7

Diagnostic Limitations

  • Not suitable for initial diagnosis alone: FNAC alone is not acceptable as a reliable diagnostic tool when morphology and immunophenotyping are both required for classification 4
  • Lymphoma diagnosis: While FNA can suggest lymphoma, excisional biopsy or core needle biopsy provides superior sensitivity (92% vs 74%) for definitive subtyping 4
  • False-negative results: Although rare, false-negative diagnoses can occur, and negative FNA should not preclude additional diagnostic procedures when clinical suspicion remains high 4

Clinical Context Considerations

  • No radical procedure on FNAC alone: Definitive surgical planning should not be based solely on FNAC results without clinical and radiological correlation 2
  • Close cooperation required: Successful FNAC of orbital lesions necessitates close cooperation between ophthalmologist, radiologist, and cytopathologist 2, 5
  • Cosmetic considerations: In the periocular region requiring great attention to cosmesis, preoperative FNAC diagnosis provides significant advantage for conservative surgical planning 1

Clinical Algorithm for FNAC in Orbital Lesions

Step 1: Clinical and Radiological Assessment

  • Perform detailed clinical examination documenting proptosis, visual changes, and mass characteristics 1, 2
  • Obtain appropriate imaging (CT or MRI) to characterize lesion location, size, and relationship to critical structures 3

Step 2: Decision for FNAC

  • Proceed with FNAC when imaging is inconclusive or when tissue diagnosis is required before definitive management 1, 2
  • Consider FNAC for suspected metastasis, recurrence, or when medical therapy (lymphoma, inflammation) is contemplated 2, 3

Step 3: Technical Execution

  • Perform ultrasound-guided FNAC when feasible to maximize adequacy 5, 3
  • Obtain multiple passes (minimum 3-7 depending on lesion type) when onsite cytopathology unavailable 4
  • Prepare both air-dried and alcohol-fixed smears plus cell block material 4
  • Collect material in appropriate media for flow cytometry if lymphoma suspected 4

Step 4: Result Interpretation and Follow-up

  • Adequate and diagnostic: Proceed with appropriate management based on diagnosis 1, 2
  • Inadequate sample: Repeat ultrasound-guided FNA with attention to sampling solid components 4, 7
  • Indeterminate result: Consider core needle biopsy or excisional biopsy based on clinical suspicion 4
  • Negative but high clinical suspicion: Do not assume benign; proceed with additional diagnostic procedures 4

Advantages Over Open Biopsy

  • Minimal morbidity: FNAC avoids complications associated with open biopsy including bleeding, infection, and scarring 6, 1
  • Preservation of anatomy: No disruption of tissue planes or cosmetic deformity in the periocular region 1
  • Rapid diagnosis: Results available within hours to days compared to weeks for surgical biopsy 6
  • Cost-effectiveness: Significantly lower cost than open surgical procedures 6, 1
  • Outpatient procedure: Can be performed in office or outpatient setting without general anesthesia 5
  • No risk of tumor seeding: Minimal risk compared to concerns with open biopsy of certain malignancies 4

Related Questions

What is the diagnosis and recommended management for a 35-year-old male patient with a palpable, firm, non-tender mass in the medial region of the right knee, adjacent to the medial collateral ligament (MCL), and a history of normal magnetic resonance imaging (MRI) and ultrasound (US) findings showing cyst-like areas versus focal fluid collections in the periarticular soft tissues?
What is the difference between Fine Needle Aspiration Cytology (FNAC) and biopsy?
Why is Fine Needle Aspiration Cytology (FNAC) preferred over incisional or open biopsy for initial diagnosis?
Why do we perform Fine Needle Aspiration Cytology (FNAC) if it can yield false negatives?
What are the next steps in management after a fine-needle aspiration cytology (FNAC) procedure results in significant reduction of swelling size with aspiration of 5cc of blood-like fluid?
What is the workup for a patient with an indeterminate Human Immunodeficiency Virus-1 (HIV-1) antibody test result?
What is the next best test to order for an adult patient with significant proteinuria (300 protein) on a random urine test?
What is the preferred treatment for an elderly male patient with a urinary tract infection (UTI) caused by Morganella morganii, which has potential resistance to trimethoprim (TMP) and sulfamethoxazole (SMX), and a history of benign prostatic hyperplasia (BPH), presenting with chills but no fever?
What is the appropriate management for a patient with acute liver failure, presenting with hyperbilirubinemia, elevated AST (Aspartate Aminotransferase), ALT (Alanine Aminotransferase), and GGT (Gamma-Glutamyl Transferase) levels, and a prolonged prothrombin time, without fever or abdominal pain?
What is an adequate margin for a patient with Medullary Thyroid Carcinoma (MTC) after total thyroidectomy?
What are the recommendations for a patient considering an orbital prosthesis after diagnosis and treatment of an orbital lesion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.